Dodge & Cox Bristol Myers Squibb CO Transaction History

Dodge & Cox

$159 Billion
Q2 2024

A detailed history of Dodge & Cox transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dodge & Cox holds 15,766,898 shares of BMY stock, worth $839 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

15,766,898

Previous 16,267,041 3.07%

Holding current value

$839 Million

Previous $882 Million 25.77%

% of portfolio

0.41%

Previous 0.54%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $20.1 Million - $26.5 Million	-500,143 Reduced 3.07%	15,766,898 $655 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $3.2 Million - $3.63 Million	66,757 Added 0.41%	16,267,041 $882 Million
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $1.59 Million - $1.9 Million	-32,824 Reduced 0.2%	16,200,284 $831 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $9.91 Million - $11.1 Million	-171,238 Reduced 1.04%	16,233,108 $942 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $4.13 Million - $4.59 Million	-64,836 Reduced 0.39%	16,404,346 $1.05 Billion
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $4.94 Million - $5.6 Million	-75,162 Reduced 0.45%	16,469,182 $1.14 Billion
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $15.8 Million - $18.7 Million	-231,218 Reduced 1.38%	16,544,344 $1.19 Billion
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $205,111 - $121 Million	-1,577,777 Reduced 8.6%	16,775,562 $1.19 Billion
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $628 Million - $692 Million	-8,650,020 Reduced 32.03%	18,353,339 $1.41 Billion
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $21.6 Million - $26 Million	-352,073 Reduced 1.29%	27,003,359 $1.97 Billion
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $62.3 Million - $72.6 Million	-1,161,925 Reduced 4.07%	27,355,432 $1.71 Billion
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $2.59 Million - $3.03 Million	43,699 Added 0.15%	28,517,357 $1.69 Billion
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $64.9 Million - $70.7 Million	1,048,325 Added 3.82%	28,473,658 $1.9 Billion
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $46.1 Million - $51.8 Million	776,638 Added 2.91%	27,425,333 $1.73 Billion
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $31.8 Million - $36.1 Million	-551,291 Reduced 2.03%	26,648,695 $1.65 Billion
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $77.8 Million - $86.3 Million	-1,355,403 Reduced 4.75%	27,199,986 $1.64 Billion
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $423 Million - $495 Million	-7,721,685 Reduced 21.29%	28,555,389 $1.68 Billion
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $649 Million - $943 Million	-13,991,703 Reduced 27.83%	36,277,074 $2.02 Billion
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $9.05 Million - $11.8 Million	-183,900 Reduced 0.36%	50,268,777 $3.23 Billion
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $34.6 Million - $41 Million	808,153 Added 1.63%	50,452,677 $2.56 Billion
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $290 Million - $321 Million	6,497,108 Added 15.06%	49,644,524 $2.25 Billion
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $25.2 Million - $30.1 Million	559,459 Added 1.31%	43,147,416 $2.06 Billion
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $469 Million - $608 Million	9,618,771 Added 29.18%	42,587,957 $2.21 Billion
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $14.6 Million - $16.4 Million	264,100 Added 0.81%	32,969,186 $2.05 Billion
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $247 Million - $308 Million	4,887,475 Added 17.57%	32,705,086 $1.81 Billion
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $77.2 Million - $88.9 Million	-1,288,500 Reduced 4.43%	27,817,611 $1.76 Billion
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $3.07 Million - $3.34 Million	51,150 Added 0.18%	29,106,111 $1.78 Billion
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $1.6 Billion - $1.85 Billion	29,054,961	29,054,961 $1.85 Billion

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account